Apollo Endosurgery Inc (APEN)
NASDAQ:APEN

Apollo Endosurgery Stock Analysis & Ratings

Apollo Endosurgery Stock Analysis Overview

Smart Score
9
Outperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Apollo Endosurgery stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

APEN

APEN Stock Stats

Previous Close$5.67
Open$5.64
Bid5.41 x 1200
Ask5.55 x 300
Today’s Range$5.32 - $5.64
52-Week Range$3.80 - $10.39
Volume54.09K
Average Volume267.85K
Market Cap$219.78M
Beta2.20
P/E Ratio-8.7
EPS-0.65
Earnings DateFeb 22, 2022

Company Description

Apollo Endosurgery Inc

Apollo Endosurgery, Inc. is a medical technology company, which engages in the design, development, and commercialization of medical devices. It offers medical devices for bariatric and gastrointestinal procedures under the ORBERA and OverStitch brands. The company was founded by Christopher J. Gostout in 2006 and is headquartered in Austin, TX.
Sector
Healthcare
Industry
Medical Devices & Instruments
CEO
Charles McKhann
Employees
158
Website
http://www.apolloendo.com
ISIN
US03767D1081
Address
1120 S. Capital of Texas Highway, Austin, TX, 78746, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

APEN FAQ

What was Apollo Endosurgery’s price range in the past 12 months?
Apollo Endosurgery lowest stock price was $3.80 and its highest was $10.39 in the past 12 months.
    What is Apollo Endosurgery’s market cap?
    Apollo Endosurgery’s market cap is $219.78M.
      What is Apollo Endosurgery’s price target?
      The average price target for Apollo Endosurgery is $12.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $13.00 ,the lowest forecast is $12.00. The average price target represents 127.67% Increase from the current price of $5.565.
        What do analysts say about Apollo Endosurgery?
        Apollo Endosurgery’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Apollo Endosurgery’s upcoming earnings report date?
          Apollo Endosurgery’s upcoming earnings report date is Feb 22, 2022 which is in 34 days.
            How were Apollo Endosurgery’s earnings last quarter?
            Apollo Endosurgery released its earnings results on Nov 01, 2021. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.242 by $0.012.
              Is Apollo Endosurgery overvalued?
              According to Wall Street analysts Apollo Endosurgery’s price is currently Undervalued.
                Does Apollo Endosurgery pay dividends?
                Apollo Endosurgery does not currently pay dividends.
                What is Apollo Endosurgery’s EPS estimate?
                Apollo Endosurgery’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Apollo Endosurgery have?
                Apollo Endosurgery has 39,490,000 shares outstanding.
                  What happened to Apollo Endosurgery’s price movement after its last earnings report?
                  Apollo Endosurgery reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.242. Following the earnings report the stock price went up 0.733%.
                    Which hedge fund is a major shareholder of Apollo Endosurgery?
                    Among the largest hedge funds holding Apollo Endosurgery’s share is Ardsley Advisory Partners. It holds Apollo Endosurgery’s shares valued at N/A.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis